Organization Statistics
Avg Compliance Rate
48.60%
Compliant Trials
486
Incompliant submissions
514
Total Organizations
46697
Total trials
1000
Filter Organizations
Compare Organization Compliance Rates
Showing 3375 of 46697 entries
View as:
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 15
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 4
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 5
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 7
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 3
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 18
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 3
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 4
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
| Sponsor | Funding Source | Total Trials | Reporting Rate | Compliant Trials | Late Submissions | Compliance Rate | Wilson LCB Score | Email Domain | Created Date |
|---|---|---|---|---|---|---|---|---|---|
| Arsenal Medical, Inc. | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Arsenal Medical, Inc..temp.org | 2025-07-14 |
| Arshad Khanani | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Arshad Khanani.temp.org | 2025-07-14 |
| Arsil Radiansyah | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Arsil Radiansyah.temp.org | 2025-07-14 |
| Arslan Saleem | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Arslan Saleem.temp.org | 2025-07-14 |
| Arstasis, Inc. | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Arstasis, Inc..temp.org | 2025-07-14 |
| Art Optical Contact Lens, Inc. | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Art Optical Contact Lens, Inc..temp.org | 2025-07-14 |
| ArtVentive Medical Group, Inc. | - | 2 | 0.0% | 0 | 0 | 0.0% | - | ArtVentive Medical Group, Inc..temp.org | 2025-07-14 |
| Artann Laboratories | - | 15 | 0.0% | 0 | 0 | 0.0% | - | Artann Laboratories.temp.org | 2025-07-14 |
| Artax Biopharma Inc | - | 4 | 0.0% | 0 | 0 | 0.0% | - | Artax Biopharma Inc.temp.org | 2025-07-14 |
| Artcline GmbH | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Artcline GmbH.temp.org | 2025-07-14 |
| Artegraft, Inc. | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Artegraft, Inc..temp.org | 2025-07-14 |
| Arterial Remodeling Technologies | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Arterial Remodeling Technologies.temp.org | 2025-07-14 |
| Arteriocyte, Inc. | - | 5 | 0.0% | 0 | 0 | 0.0% | - | Arteriocyte, Inc..temp.org | 2025-07-14 |
| Arteriogenesis Competence Network | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Arteriogenesis Competence Network.temp.org | 2025-07-14 |
| Artery Therapeutics, Inc. | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Artery Therapeutics, Inc..temp.org | 2025-07-14 |
| Artgen Biotech | - | 7 | 0.0% | 0 | 0 | 0.0% | - | Artgen Biotech.temp.org | 2025-07-14 |
| Arthesys | - | 3 | 0.0% | 0 | 0 | 0.0% | - | Arthesys.temp.org | 2025-07-14 |
| Arthrex GmbH | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Arthrex GmbH.temp.org | 2025-07-14 |
| Arthrex SAS | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Arthrex SAS.temp.org | 2025-07-14 |
| Arthrex, Inc. | - | 18 | 0.0% | 0 | 0 | 0.0% | - | Arthrex, Inc..temp.org | 2025-07-14 |
| Arthritis & Rheumatic Disease Specialties Research | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Arthritis & Rheumatic Disease Specialties Research.temp.org | 2025-07-14 |
| Arthritis & Rheumatism Associates, P.C. | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Arthritis & Rheumatism Associates, P.C..temp.org | 2025-07-14 |
| Arthritis Foundation | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Arthritis Foundation.temp.org | 2025-07-14 |
| Arthritis Innovation Corporation | - | 3 | 0.0% | 0 | 0 | 0.0% | - | Arthritis Innovation Corporation.temp.org | 2025-07-14 |
| Arthritis Northwest PLLC | - | 4 | 0.0% | 0 | 0 | 0.0% | - | Arthritis Northwest PLLC.temp.org | 2025-07-14 |